FOXP1 is a Transcription Factor for the Alzheimer's Disease Risk Gene SORL1
Journal of Neurochemistry · 2025-02 · 169 (2)
DOI: 10.1111/jnc.70011 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Neurochemistry, online erschienen am 04.02.2025. Verfasst von Xiaofeng Fu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Innovation Center for Neurological Disorders and Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China. Hauptthemen laut MEDLINE: Alzheimer Disease, Forkhead Transcription Factors, Membrane Transport Proteins, LDL-Receptor Related Proteins. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: Capital's Funds for Health Improvement and Research, Beijing Municipal Natural Science Foundation, Beijing Brain Initiative from Beijing Municipal Science & Technology Commission.
Themen: Demenz
Abstract (Originalsprache)
Sortilin‐related receptor 1 ( SORL1 ) is a risk gene of Alzheimer's disease (AD), and some protein‐truncating (PTV) and rare missense variants causing the loss of function of SORL1 contribute to AD pathogenesis. SORL1 is an endosomal receptor that interacts with multiple protein sorting complexes to facilitate the transport of various cargoes through the endolysosomal network (ELN). However, the regulatory mechanisms governing SORL1 expression remain unknown. Through biochemical methods, we identified Forkhead Box P1 (FOXP1) as a binding protein to the minimal promoter region of SORL1 gene. Silencing FOXP1 using siRNA significantly decreased the activity of the SORL1 minimal promoter and reduced SORL1 protein and mRNA levels in the neuroblastoma cell line SH‐SY5Y. Additionally, using 5xFAD mouse models of AD, we observed significantly decreased FOXP1 and SORL1 expression in neurons within the prefrontal cortex. Disruption of ELN and the autophagy degradation system by bafilomycin A1 (BafA1) appeared to be a specific condition to suppress FOXP1 and hence SORL1 in SH‐SY5Y cells. These findings highlight the critical role of FOXP1 in regulating SORL1 expression and suggest that FOXP1 could be a potential target to maintain SORL1 expression for AD prevention and therapy. image
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Innovation Center for Neurological Disorders and Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China.
- The National Clinical Research Center for Geriatric Disease, Xuanwu Hospital, Capital Medical University, Beijing, China.
ORCID-Profile: Longfei Jia
Förderung
- Capital's Funds for Health Improvement and Research
- Beijing Municipal Natural Science Foundation
- Beijing Brain Initiative from Beijing Municipal Science & Technology Commission
- National Natural Science Foundation of China
- Beijing Municipal Administration of Hospitals' Ascent Plan
- STI2030-Major Projects
- Natural Science Foundation of Beijing Municipality
Zitieren
APA
Fu, X., Quan, S., Liang, W., Li, Y., Cai, H., Ren, Z., Xu, Y., Wang, Z., & Jia, L. (2025). FOXP1 is a Transcription Factor for the Alzheimer's Disease Risk Gene SORL1. Journal of Neurochemistry, 169(2). https://doi.org/10.1111/jnc.70011
Vancouver
Fu X, Quan S, Liang W, Li Y, Cai H, Ren Z, et al. FOXP1 is a Transcription Factor for the Alzheimer's Disease Risk Gene SORL1. Journal of Neurochemistry. 2025;169(2). doi:10.1111/jnc.70011
BibTeX
@article{Fu2025,
author = {Fu, Xiaofeng and Quan, Shuiyue and Liang, Wenping and Li, Yu and Cai, Huimin and Ren, Ziye and Xu, Yinghao and Wang, Zhe and Jia, Longfei},
title = {FOXP1 is a Transcription Factor for the Alzheimer's Disease Risk Gene SORL1},
journal = {Journal of Neurochemistry},
year = {2025},
volume = {169},
number = {2},
doi = {10.1111/jnc.70011}
}
EUVIMED